drugset / Trial / NCT03759262

Ultra-high Dose Vitamin D for HSCT

NCT03759262

Phase 1 Completed 33 enrolled Children's Hospital Los Angeles
NaSingle-groupOpen-labelSupportive care

Summary

This is a pilot study to investigate the effects of achieving adequate vitamin D levels via ultra-high-dose vitamin D supplementation given prior to hematopoietic stem cell transplant on transplant-related complications and inflammatory biomarkers.

Timeline

Start
2018-12-10
Primary completion
2020-05-10
Completion
2020-05-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified Oral